A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Imperial College London
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Genmab
Kineta Inc.
Revolution Medicines, Inc.
University Health Network, Toronto
Revolution Medicines, Inc.
Exact Sciences Corporation
Imperial College London
SpeciCare
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center
New Mexico Cancer Research Alliance
Astellas Pharma Inc